QS Investors’s NxStage Medical Inc. NXTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-94,348
Closed -$2.7M 1953
2018
Q4
$2.7M Hold
94,348
0.03% 411
2018
Q3
$2.63M Sell
94,348
-14
-0% -$394 0.03% 532
2018
Q2
$2.63M Hold
94,362
0.03% 517
2018
Q1
$2.35M Sell
94,362
-6,121
-6% -$149K 0.02% 526
2017
Q4
$2.44M Sell
100,483
-790
-0.8% -$20.8K 0.02% 539
2017
Q3
$2.79M Sell
101,273
-3,470
-3% -$92.5K 0.02% 495
2017
Q2
$2.63M Sell
104,743
-769
-0.7% -$19K 0.02% 507
2017
Q1
$2.83M Buy
105,512
+1,600
+2% +$44.2K 0.02% 493
2016
Q4
$2.72M Sell
103,912
-33,710
-24% -$834K 0.02% 531
2016
Q3
$3.44M Hold
137,622
0.03% 498
2016
Q2
$2.98M Buy
137,622
+14
+0% +$250 0.03% 542
2016
Q1
$2.06M Buy
137,608
+20,796
+18% +$348K 0.02% 636
2015
Q4
$2.56M Buy
+116,812
New +$2.18M 0.02% 590

Other funds holding NXTM

QS Investors's NXTM Position: Q1 2019 in Review

QS Investors sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 94,348 shares — an estimated $2.7M sold.

QS Investors first reported a position in NXTM in Q4 2015 and held it in 13 quarters. The position peaked at $3.44M in Q3 2016. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.

  • QS Investors reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
  • QS Investors sold 94,348 NxStage Medical Inc. shares in Q1 2019, an estimated $2.7M.
  • QS Investors first reported a position in NxStage Medical Inc. in Q4 2015 and held it in 13 quarters.
  • QS Investors's NxStage Medical Inc. position peaked at $3.44M in Q3 2016.
  • 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.

Based on QS Investors's 13F filing for Q1 2019, filed 15 May 2019.